OPA1 and autosomal dominant optic atrophy: The generated human RGC model of ADOA plus harboring the pathogenic variant c.1861C>T (p.Gln621Ter) in OPA1 recapitulates the main biochemical features of the disease, and therefore it could be employed as a future platform to perform high-throughput drug screenings.